Hyperphagia: Clinical Trials

4 trials for Hyperphagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 2, Active not recruiting 1, Not yet recruiting 1

Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing an Intervention for College Students With Food Insecurity and Binge Eating
novel binge eating intervention for college students experiencing food insecurity. - Binge Eating
Early Phase 1Not yet recruitingVirginia Polytechnic Institute and State University102026-12-012026-04-09
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
GLY-LOW - Insulin Resistance, Obesity
Early Phase 1CompletedHoskinson Health and Wellness Clinic132023-07-272025-06-10
Naltrexone Neuroimaging in Teens With Eating Disorders
Naltrexone, Placebo - Eating Disorders, Binge Eating
Early Phase 1Active not recruitingChildren's Mercy Hospital Kansas City602022-09-172026-10-16
Naltrexone Neuroimaging
Naltrexone - Eating Disorders, Binge Eating
Early Phase 1CompletedChildren's Mercy Hospital Kansas City132021-07-162023-10-12

Narrower conditions

Bulimia (3)  ·  Feeding and Eating Disorders (2)  ·  Anorexia Nervosa (1)  ·  Bulimia Nervosa (1)  ·  Cardiovascular Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Hyperlipidemias (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Obesity (1)  ·  Sedentary Behavior (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Digestive (4)  ·  Mental Disorders (3)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Body Weight (1)  ·  Cognition Disorders (1)  ·  Dyslipidemias (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Neurocognitive Disorders (1)

Interventions

Naltrexone (2)

Sponsors

Children's Mercy Hospital Kansas City (2)  ·  Hoskinson Health and Wellness Clinic (1)  ·  Virginia Polytechnic Institute and State University (1)

Countries

United States (3)

Top investigators

Stephani Stancil, PhD (2)  ·  Sanjay Dhar, PhD (1)

Results publications

PMID 37492067, PMID 40043750

NIH funding

K23MH130728 (1), UL1TR002366 (1)